The presence of a high CD8+ T/Treg cell ratio predicting ICB responsiveness in only 14% of MM cases may provide a scientific rationale to the negative results of the anti-PD-1 monoclonal antibody in past clinical trials15,16,39. Here, CD8A is linked to Miyoshi myopathy.